US HB7970 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on April 11 2024 - 25% progression
Action: 2024-04-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 11 2024 - 25% progression
Action: 2024-04-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require direct-to-consumer advertisements for prescription drugs and biological products to include truthful and not misleading pricing information.
Title
Plain Prescription Prices Act
Sponsors
| Rep. Nikema Williams [D-GA] | Rep. Katie Porter [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-04-12 | House | Referred to the Subcommittee on Health. |
| 2024-04-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2024-04-11 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/7970/all-info |
| Text | https://www.congress.gov/118/bills/hr7970/BILLS-118hr7970ih.pdf |
